<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0995">
 <label>199</label>
 <element-citation publication-type="journal" id="sbref0995">
  <person-group person-group-type="author">
   <name>
    <surname>Uhl</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Helm</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Hofhaus</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Brings</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kaufman</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Leotta</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>A liposomal formulation for the oral application of the investigational hepatitis B drug myrcludex B</article-title>
  <source>Eur. J. Pharm. Biopharm.</source>
  <volume>103</volume>
  <year>2016</year>
  <fpage>159</fpage>
  <lpage>166</lpage>
  <pub-id pub-id-type="pmid">27049970</pub-id>
 </element-citation>
</ref>
